touchPODCAST

touchTALKS for touchONCOLOGY

Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future.

The expert

• Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain

This touchPODCAST is for HCPs outside of the UK only.

This activity is funded by an independent medical education grant from Pfizer.

This activity is provided by touchIME.

touchIME is an EBAC® accredited provider. 

For further information visit our website: www.touchONCOLOGY.com

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into personalized treatment plans.

The experts:

• Dr Anat Galor – Bascom Palmer Eye Institute, Miami, USA
• Dr Christopher Starr – Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, USA
• Dr Marjan Farid – University of California Irvine Medical Center, Irvine, USA

This touchPODCAST is for healthcare professionals in the USA, Canada and Latin America

This activity is funded by an independent medical education grant from Alcon Vision LLC.

This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchophthalmologyime.org

touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY

 

Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient management.

The experts:

• Prof. Marina Garassino, University of Chicago, IL, USA
• Prof. Jakob Nikolas Kather, Technical University, Dresden and University Hospital Dresden, Germany
• Prof. Fernando Lopez-Rios, Hospital Universitario 12 de Octubre, Madrid, Spain

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from AstraZeneca.

The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our websites:

touchONCOLOGY: https://touchoncologyime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/

touchRESPIRATORY: https://touchrespiratoryime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC.  The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care.

The experts:

• Dr Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States
• Prof. Michel Ducreux - Gustave Roussy Cancer Center, Villejuif, France
• Dr Thomas Hope - University of California, San Francisco, CA, USA

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A.

The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchONCOLOGY.com 

touchEXPERT FOCUS for touchOPHTHALMOLOGY

 

Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression.

The expert:

• Dr Maria-João Menéres, ULS Santo António, Porto, Portugal

This touchPODCAST is for HCPs in Portugal only.

This activity is funded by an independent medical education grant from Alimera Sciences Europe Limited.

The activity is provided by touchIME.
touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchOPHTHALMOLOGY.com   

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperative counselling to set realistic expectations and improve patient satisfaction through clear, effective communication.

 

The expert:

• Prof. Sumit (Sam) Garg, University of California, Irvine, CA, USA

This touchPODCAST is for HCPs outside of the UK.

This educational activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc.

This activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

 

For further information visit our website: 

https://touchophthalmology.org

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY

Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors.

The experts

• Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA
• Dr Elias Jabbour, MD Anderson Cancer Center, Houston, TX, USA 
• Dr Vivian Oehler, Fred Hutch Cancer Center, Seattle, WA, USA

This touchPODCAST is for HCPs in the USA only.

This activity is funded by an independent medical education grant from Takeda Development Center Americas, Inc.

Jointly provided by Partners for Advancing Clinical Education and touchIME.

For further information, visit our websites: 
www.touchHAEMATOLOGY.com
www.touchONCOLOGY.com

touchEXPERT FOCUS for touchENDOCRINOLOGY

Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary framework.

The expert:

• Dr Ashley Shoemaker, Vanderbilt University Medical Center, Nashville, TN, USA

This touchPODCAST is for HCPs in the USA only.

This activity is funded by an independent medical education grant from Soleno Therapeutics.

The activity is jointly provided by Partners for Advancing Clinical Education (Partners) and touchIME.

 

For further information, visit our website: https://touchendocrinologyime.org/hyperphagia-pws-recognition-management/

touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY

 

Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs.

The expert(s)

• Dr Lyudmila Bazhenova, Moore’s Cancer Center, San Diego, CA, USA
• Dr Elvire Pons-Tostivint, Nantes Université, Centre Hospitalier Universitaire Nantes, France
• Dr Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA

This touchPODCAST is for HCPs only outside of the UK.

This activity is funded by an independent medical education grant fromAstraZeneca.

This activity is jointly provided by USF Health and touchIME. 
touchIME is an EBAC® accredited provider.

For further information visit our websites: 

www.touchONCOLOGY.com
www.touchRESPIRATORY.com

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY

Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice.

The experts:

• Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy
• Dr Austin Kulasekararaj, King’s College Hospital NHS Foundation Trust, London, UK
• Dr Srikanth Nagalla, Miami Cancer Institute, Miami, FL, USA

This touchPODCAST is for HCPs outside of the UK.

This activity is funded by an independent medical education grant from Alexion Pharma GmbH.

The activity is jointly provided by USF Health and touchIME.

touchIME is an EBAC® accredited provider.

For further information visit our website: www.touchHAEMATOLOGY.com or www.touchONCOLOGY.com